Trials / Recruiting
RecruitingNCT05365425
Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
Effect of Choline Fenofibrate on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes and Combined Dyslipidemia
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 56 (estimated)
- Sponsor
- Seoul National University Bundang Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized controlled study to assess the effect of choline fenofibrate compared with policosanol in Korean T2DM patients with asymptomatic atherosclerosis.
Detailed description
In patients with type 2 diabetes with atherosclerotic combined dyslipidemia, the effect of choline fenofibrate on the progression of carotid intima media thickness and carotid artery plaque will be evaluated by 3D carotid ultrasound.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Choline fenofibrate | choline fenofibrate 178.8mg (135mg as fenofibric acid) |
| DRUG | Policosanol | policosanol 10mg |
Timeline
- Start date
- 2023-06-01
- Primary completion
- 2025-12-31
- Completion
- 2026-12-31
- First posted
- 2022-05-09
- Last updated
- 2024-05-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05365425. Inclusion in this directory is not an endorsement.